(Q39816294)

14 September 2017

title

Clinical significance of the highly sensitive fucosylated fraction of α-fetoprotein in patients with chronic liver disease (English)

1 reference

14 September 2017

main subject

chronic liver disease

0 references

8

Yoshikazu Kinoshita

1 reference

14 September 2017

Takuya Hanaoka

1

1 reference

14 September 2017

Shuichi Sato

2

1 reference

14 September 2017

Hiroshi Tobita

3

1 reference

14 September 2017

Tatsuya Miyake

4

1 reference

14 September 2017

Shunji Ishihara

5

1 reference

14 September 2017

Shuji Akagi

6

1 reference

14 September 2017

Yuji Amano

7

1 reference

14 September 2017

publication date

1 April 2011

1 reference

Journal of Gastroenterology and Hepatology

14 September 2017

published in

1 reference

14 September 2017

volume

26

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

739-744

1 reference

NIH conference. Hepatocellular carcinoma

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Electrokinetic analyte transport assay for alpha-fetoprotein immunoassay integrates mixing, reaction and separation on-chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06585.X

10.1111/J.1440-1746.2010.06585.X

21 January 2018

Identifiers

DOI

1 reference

release_qcribavxyvekdh23ndszqp474y

14 September 2017

Fatcat ID

0 references

1 reference